Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

Long-lasting pain relief without opioids: UB researchers develop a novel, local treatment for chronic pain
10/4/21
An investigation into the origins of the sensation of pain has led to the development of a novel and durable treatment for inflammatory pain that could be a promising alternative to opioids.
Aerobic exercise after a sport-related concussion speeds recovery in adolescent athletes
9/30/21
Adolescents can speed their recovery after a sport-related concussion and reduce their risk of experiencing protracted recovery if they engage in aerobic exercise within 10 days of getting injured.
Dental care: The best, worst and unproven tools to care for your teeth, according to a UB study
9/29/21
Only a handful of oral hygiene tools actually prevent gum disease. At the moment, all other tools are only supported by insufficient evidence, say UB researchers.
New treatment uses reverse vaccination to teach immune system not to attack life-saving drugs
9/29/21
The treatment could be applied to a broad range of drug therapies, autoimmune disorders and allergies.
Stimulating the ear’s pressure points could help treat chronic abdominal pain in children and adolescents
9/27/21
A type of acupressure focused on pressure points in the ear could be a promising treatment for a challenging group of disorders that cause chronic abdominal pain in 13.5% of children and adolescents.
Two UB faculty win Fulbright awards
9/27/21
Diana Aga and Robert M. Straubinger are UB's newest faculty recipients of the prestigious international awards.
Study finds no association between caffeine intake and invasive breast cancer risk
9/27/21
Overlap of age at diagnosis of breast cancer and age with high consumption of caffeine, and inconsistent findings from previous studies, motivated researchers to study whether caffeine could affect breast cancer risk.
In a gene tied to growth, scientists see glimmers of human history
9/24/21
A paper in Science Advances focuses on the evolution of the human growth hormone receptor gene.
UB professor Donald Mager named FIP fellow for international leadership in pharmacy
9/23/21
The fellowship recognizes FIP members who have exhibited leadership internationally, and distinguished themselves in and contributed to the advancement of the pharmaceutical sciences and practice of pharmacy.
Could AI help optimize aneurysm surgeries?
9/23/21
UB spinoff QAS.AI is developing software — trained on past cases — to inform decision-making during surgical procedures.

Next> <Previous